On October 22, 3SBIO fell 5.25% in Regular Trading, trading at HK$13.55, with turnover of HK$193 million.
The clearest catalyst in publicly available information is a recent broker action: UBS downgraded the company to Neutral, which coincided with renewed selling pressure in the stock.
Recent disclosures also show 3SBIO had been actively repurchasing shares, including 2.5 million shares on October 9 for about HK$37.59 million, 1.0 million shares on October 12 for about HK$14.80 million, 0.8 million shares on October 13 for about HK$11.65 million, and 337,500 shares on October 14 for about HK$4.86 million. Even so, the current share price is below the company’s recent buyback price range of HK$14.40 to HK$15.75, indicating that the rating downgrade has overshadowed buyback support in the near term.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments